Table 2 Frequency of healthcare exposures occurring prior to PVE (n = 1266)
From: Healthcare exposures and associated risk of endocarditis after open-heart cardiac valve surgery
Exposure | Count within 30Â days of PVEa | Count within 90Â days of PVEa | Count within 6Â months of PVEa |
|---|---|---|---|
Any healthcare exposureb | 253 (20.0%) | 473 (37.4%) | 611 (48%) |
Red cell transfusion | 40 (3.2%) | 75 (5.9%) | 111 (8.8%) |
Gastroscopy | 18 (1.4%) | 42 (3.3%) | 67 (5.3%) |
Colonoscopy | 8 (0.6%) | 39 (3.0%) | 64 (5.1%) |
Coronary angiogram | 18 (1.4%) | 35 (2.8%) | 46 (3.6%) |
Hemodialysis | 23 (1.8%) | 26 (2.1%) | 30 (2.4%) |
Pacing wire insertion | 5 (0.4%) | 16 (1.3%) | 28 (2.2%) |
Cystoscopy | 6 (0.5%) | 14 (1.1%) | 29 (2.3%) |
Central venous catheter insertion | 4 (0.3%) | 12 (0.9% | 16 (1.3%) |
Open-heart cardiac valve surgeryc | 3 (0.2%) | 8 (0.6%) | 9 (0.7%) |
Skin biopsy | 2 (0.2%) | 4 (0.3%) | 4 (0.3%) |
Chemotherapy | 1 (0.1%) | 1 (0.1%) | 2 (0.2%) |
Bronchoscopy | 0 (0%) | 2 (0.2%) | 2 (0.2%) |
Coronary artery bypass graft | 0 (0%) | 0 (0%) | 1 (0.1%) |